Navigating the future-scape of pharmaceutical medicine
The 2023 FPM Annual Symposium – Navigating the future-scape of pharmaceutical medicine – addressed some of the biggest challenges and the most exciting opportunities facing global healthcare. As countries and healthcare systems around the world have been doing their best to recover from COVID-19, the lessons the pandemic taught are being infused into a new pioneering and collaborative spirit.
FPM Annual Symposium 2023 is now available as an On-Demand package!
This event is now closed for booking.
- £150 member rate
- £200 non-member rate
- £100 reduced rate*
- *Reduced rates are available for FPM members who fulfil one of the following criteria: PMST trainees, people from low and lower-middle income countries, unemployed, part-time employed (earning less than £15,000 per year), people on Parental Leave, people who are Out of Practice & Retired, those who work for a charity.
- Please see our terms and conditions
You can find instructions and guidance regarding CPD eligibility here.
Please allow up to 2 working days for your booking to be processed and for your access link to be sent to you. Please don’t forget to check your junk folder!
Joining instructions will be emailed to registered attendees periodically, with a final reminder email sent one hour (online events) prior to the event. Please don’t forget to check your junk folder!
Queries: If you are unable to complete your booking online or have any questions, please email firstname.lastname@example.org
Meet the speakers
Delve deeper into our speakers’ background by taking a look at our speakers page.
Prof Kevin Fenton
President of the Faculty of Public Health and the Regional Director for London in the Office for Health Improvement and Disparities
Sir Jon Symonds
Chairman of the Board of GSK
Dr Trishan Panch
President, Harvard TH Chan School of Public Health Alumni Association
Dr Juliet Addo
Academic Engagement Director, Global Health & Head of the Africa Open Lab at GSK
Co-Founder & CEO – Neurosynaptic Communications Pvt. Ltd.
Dr Pauline Williams FFPM
Independent Consultant in Global Health and Translational Medicine
Dr Craig Tipple
Medical Director (CMO), Drugs for Neglected Diseases initiative
Prof Frances Flinter
Emeritus Professor of Clinical Genetics
Chief Partnerships Officer, Cancer Lead, Genomics England
Dr Jeymi Tambiah MFPM(Dis)
Senior Vice President, Clinical Development and External Innovation, Biosplice Therapeutics, San Diego
Dr Rav Seeruthun FFPM
Chief Medical Officer and co-founder of health-equity.ai.
VP & Head, Safety Innovation & Analytics, GSK
Dr Emma Iovoli MFPM
Life Sciences Consultant
Dr Alan Dangour
Director, Climate & Health – Wellcome Trust
Dr Fiona Adshead
Chair, Sustainable Healthcare Coalition
Head of Medical Affairs for Roche Diagnostics UK & Ireland
Founder and CEO of IBDrelief
Global Head of Digital Health and Innovation at Fortrea
Dr Richard Gorman
Research Fellow at Brighton and Sussex Medical School
Founder member and current Board and Executive Committee member of Patient Focused Medicines Development (PFMD)
Dr Liz Clark FFPM
Visiting Lecturer and Patient Engagement Theme Lead at the Centre for Pharmaceutical Medicines Research
Dr Julie Warner
Vice President, Regulatory Affairs, Boyds
Principal Consultant at Decisive Consulting
Dr Kirsty Wydenbach MFPM
Head of Regulatory Strategy at Weatherden
Dr Amit Aggarwal MFPM
Executive Director for Medical Affairs at the ABPI
Dr Alison Cave
Chief Safety Officer, Medicines and Healthcare products Regulatory Agency
Dr Nick Broughton MFPM
Educator and Founding Partner, Ethos Pharmaceutical Ethics and Compliance Ltd.
Dr June Raine FFPM
CEO of the Medicines and Healthcare products Regulatory Agency
Dr David Jefferys FFPM
Senior Vice President, Eisai
Professor Andrew Farmer
Professor of General Practice, University of Oxford and Director, NIHR Health Technology Assessment Programme
Dr Lisa Broad
Vice President and Head of Neurodegeneration Discovery, Lilly and Managing Director of Lilly Research Labs, UK
Professor Alan Boyd FFPM
Past-President of FPM and CEO of Boyds
Dr Karen Mullen FFPM
Chief Medical Officer (CMO) & Vice President of Clinical and Medical Affairs, Boyds